164 related articles for article (PubMed ID: 35924577)
41. Identification of an alternative short ARID5B isoform associated with B-ALL survival.
Chalise JP; Hu Z; Li M; Shepphird JK; Gu Z; Gyawali P; Itakura K; Larson GP
Biochem Biophys Res Commun; 2024 Apr; 703():149659. PubMed ID: 38382358
[TBL] [Abstract][Full Text] [Related]
42. Novel phenotypes observed in patients with
Karastaneva A; Nebral K; Schlagenhauf A; Baschin M; Palankar R; Juch H; Heitzer E; Speicher MR; Höfler G; Grigorow I; Urban C; Benesch M; Greinacher A; Haas OA; Seidel MG
J Med Genet; 2020 Jun; 57(6):427-433. PubMed ID: 31704777
[No Abstract] [Full Text] [Related]
43. Enhancer polymorphisms at the IKZF1 susceptibility locus for acute lymphoblastic leukemia impact B-cell proliferation and differentiation in both Down syndrome and non-Down syndrome genetic backgrounds.
Gant VU; Junco JJ; Terrell M; Rashid R; Rabin KR
PLoS One; 2021; 16(1):e0244863. PubMed ID: 33411777
[TBL] [Abstract][Full Text] [Related]
44. Regional evaluation of childhood acute lymphoblastic leukemia genetic susceptibility loci among Japanese.
Urayama KY; Takagi M; Kawaguchi T; Matsuo K; Tanaka Y; Ayukawa Y; Arakawa Y; Hasegawa D; Yuza Y; Kaneko T; Noguchi Y; Taneyama Y; Ota S; Inukai T; Yanagimachi M; Keino D; Koike K; Toyama D; Nakazawa Y; Kurosawa H; Nakamura K; Moriwaki K; Goto H; Sekinaka Y; Morita D; Kato M; Takita J; Tanaka T; Inazawa J; Koh K; Ishida Y; Ohara A; Mizutani S; Matsuda F; Manabe A
Sci Rep; 2018 Jan; 8(1):789. PubMed ID: 29335448
[TBL] [Abstract][Full Text] [Related]
45. Expression of aberrantly spliced oncogenic ikaros isoforms in childhood acute lymphoblastic leukemia.
Sun L; Goodman PA; Wood CM; Crotty ML; Sensel M; Sather H; Navara C; Nachman J; Steinherz PG; Gaynon PS; Seibel N; Vassilev A; Juran BD; Reaman GH; Uckun FM
J Clin Oncol; 1999 Dec; 17(12):3753-66. PubMed ID: 10577847
[TBL] [Abstract][Full Text] [Related]
46. The Role of ARID5B in Acute Lymphoblastic Leukemia and Beyond.
Wang P; Deng Y; Yan X; Zhu J; Yin Y; Shu Y; Bai D; Zhang S; Xu H; Lu X
Front Genet; 2020; 11():598. PubMed ID: 32595701
[TBL] [Abstract][Full Text] [Related]
47. Genetic susceptibility in childhood acute lymphoblastic leukemia.
Gutierrez-Camino A; Martin-Guerrero I; García-Orad A
Med Oncol; 2017 Sep; 34(10):179. PubMed ID: 28905228
[TBL] [Abstract][Full Text] [Related]
48. Expression of E2A-HLF chimeric protein induced T-cell apoptosis, B-cell maturation arrest, and development of acute lymphoblastic leukemia.
Honda H; Inaba T; Suzuki T; Oda H; Ebihara Y; Tsuiji K; Nakahata T; Ishikawa T; Yazaki Y; Hirai H
Blood; 1999 May; 93(9):2780-90. PubMed ID: 10216071
[TBL] [Abstract][Full Text] [Related]
49. ARID5B rs7089424 and rs10994982 and association with B-lineage ALL susceptibility.
Joob B; Wiwanitkit V
J Chin Med Assoc; 2019 Dec; 82(12):966. PubMed ID: 31800538
[No Abstract] [Full Text] [Related]
50. Reply to "ARID5B rs7089424 and rs10994982 and association with B-lineage ALL susceptibility".
Tao R; Li W; Liu YJ
J Chin Med Assoc; 2019 Dec; 82(12):967. PubMed ID: 31800539
[No Abstract] [Full Text] [Related]
51. Reduced prostaglandin I
Murray J; Whitson RH; Itakura K
FASEB J; 2018 Apr; 32(4):1868-1879. PubMed ID: 29196500
[TBL] [Abstract][Full Text] [Related]
52. Association of ARID5B Genetic Variants with Risk of Childhood B Cell Precursor Acute Lymphoblastic Leukaemia in Latvia.
Kreile M; Rots D; Zarina A; Rautiainen L; Visnevska-Preciniece Z; Kovalova Z; Gailite L
Asian Pac J Cancer Prev; 2018 Jan; 19(1):91-95. PubMed ID: 29373897
[TBL] [Abstract][Full Text] [Related]
53. Aberrant ARID5B expression and its association with Ikaros dysfunction in acute lymphoblastic leukemia.
Ge Z; Han Q; Gu Y; Ge Q; Ma J; Sloane J; Gao G; Payne KJ; Szekely L; Song C; Dovat S
Oncogenesis; 2018 Nov; 7(11):84. PubMed ID: 30420689
[TBL] [Abstract][Full Text] [Related]
54. Knockdown of AT-rich interaction domain (ARID) 5B gene expression induced AMPKα2 activation in cardiac myocytes.
Hirose-Yotsuya L; Okamoto F; Yamakawa T; Whitson RH; Fujita-Yamaguchi Y; Itakura K
Biosci Trends; 2015 Dec; 9(6):377-85. PubMed ID: 26781795
[TBL] [Abstract][Full Text] [Related]
55. Muscle-specific deletion of
Murray J; Ehsani A; Najjar L; Zhang G; Itakura K
Front Endocrinol (Lausanne); 2022; 13():1083311. PubMed ID: 36743919
[TBL] [Abstract][Full Text] [Related]
56. Genetic variants modify susceptibility to leukemia in infants: a Children's Oncology Group report.
Ross JA; Linabery AM; Blommer CN; Langer EK; Spector LG; Hilden JM; Heerema NA; Radloff GA; Tower RL; Davies SM
Pediatr Blood Cancer; 2013 Jan; 60(1):31-4. PubMed ID: 22422485
[TBL] [Abstract][Full Text] [Related]
57. AT-rich interactive domain 5B regulates androgen receptor transcription in human prostate cancer cells.
Yamakawa T; Waer C; Itakura K
Prostate; 2018 Dec; 78(16):1238-1247. PubMed ID: 30027545
[TBL] [Abstract][Full Text] [Related]
58. Concise review: Blood relatives: formation and regulation of hematopoietic stem cells by the basic helix-loop-helix transcription factors stem cell leukemia and lymphoblastic leukemia-derived sequence 1.
Curtis DJ; Salmon JM; Pimanda JE
Stem Cells; 2012 Jun; 30(6):1053-8. PubMed ID: 22593015
[TBL] [Abstract][Full Text] [Related]
59. Increased glucose metabolism in Arid5b
Okazaki Y; Murray J; Ehsani A; Clark J; Whitson RH; Hirose L; Yanaka N; Itakura K
Biol Res; 2020 Oct; 53(1):45. PubMed ID: 33023658
[TBL] [Abstract][Full Text] [Related]
60. Genetic defects in hematopoietic transcription factors and predisposition to acute lymphoblastic leukemia.
Gocho Y; Yang JJ
Blood; 2019 Sep; 134(10):793-797. PubMed ID: 31311817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
